Multicenter phase II study in advanced pancreatic adenocarcinoma patients treated with a combination of leucovorin, 5FU bolus and infusion, and emcitabine (FOLFUGEM regimen).

被引：0
|
作者：
Hammel, P [1 ]
Louvet, C [1 ]
Andre, T [1 ]
Vanica, R [1 ]
Landi, B [1 ]
Balosso, J [1 ]
Cattan, S [1 ]
Fonck, M [1 ]
Flesch, M [1 ]
Colin, P [1 ]
Gruson, T [1 ]
de Gramont, A [1 ]
机构：
[1] Hosp Beaujon, Clichy, France
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1828
引用
收藏
页码：A417 / A417
页数：1
相关论文
共 50 条
  • [31] Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma
    Andre, T
    Lotz, JP
    Bouleuc, C
    Azzouzi, K
    Houry, S
    Hannoun, L
    See, J
    Esteso, A
    Avenin, D
    Izrael, V
    ANNALS OF ONCOLOGY, 1996, 7 (02) : 173 - 178
  • [32] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [33] PHASE II STUDY OF PREOPERATIVE OXALIPLATIN AND 5FU WITH CONCURRENT RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
    Chao, M.
    Field, K.
    McLaughlin, S.
    Jones, I
    Hayes, I
    Faragher, I
    Skinner, I
    Gibbs, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 108 - 108
  • [34] Update of a phase I-II study of biweekly irinotecan in combination with gemcitabine (G), 5FU (F), leucovorin (LV) and cisplatin (G-GLIP) in patients with metastatic pancreatic cancer.
    Goel, A
    Malamud, S
    Grossbard, M
    Homel, P
    Dietrich, M
    Kozuch, P
    Mirzoyev, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 335S - 335S
  • [35] A PHASE III STUDY OF ADRIAMYCIN + 5FU VS BCNU + ADRIAMYCIN + FTORAFUR FOR PATIENTS WITH ADVANCED PANCREATIC-CANCER
    FRIEDMAN, MA
    CASSIDY, MJ
    HANNIGAN, JF
    GRIBBLE, M
    TORTI, FM
    REYNOLDS, RD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 156 - 156
  • [36] Phase I/II study of irinotecan (CPT-11) combined with 1-leucovorin (I-LV) and 5FU in patients with advanced colorectal cancer
    Komatsu, Y
    Takei, M
    Kato, T
    Miyagishima, T
    Kunieda, Y
    Tateyama, M
    Wakahama, O
    Takeda, H
    Kato, M
    Sugiyama, T
    Asaka, M
    Sakata, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 437 - 437
  • [37] Phase I Study of Combination Therapy with Irinotecan, Leucovorin, and Bolus and Continuous-infusion 5-Fluorouracil (FOLFIRI) for Advanced Colorectal Cancer in Japanese Patients
    Sasaki, Yusuke
    Hamaguchi, Tetsuya
    Arai, Tatsuhiro
    Goto, Ayumu
    Ura, Takashi
    Muro, Kei
    Yamada, Yasuhide
    Shirao, Kuniaki
    Shimada, Yasuhiro
    ANTICANCER RESEARCH, 2014, 34 (04) : 2029 - 2034
  • [38] Oxaliplatin, 5FU and nab-paclitaxel as neoadjuvant regimen in patients with resectable oesogastric adenocarcinoma: A GERCOR phase 2 study (FOXAGAST).
    Watson, Sarah Sophie
    De La Fouchardiere, Christelle
    Kim, Stefano Chong Hun
    Cohen, Romain
    Bachet, Jean-Baptiste
    Tournigand, Christophe
    Ferraz, Jean-Marc
    Lefevre, Marine
    Colin, Delphine
    Svrcek, Magali
    Meurisse, Aurelia
    Louvet, Christophe
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer
    Chiou, TJ
    Tung, SL
    Hsieh, RK
    Wang, WS
    Yen, CC
    Fan, FS
    Liu, JH
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1998, 28 (05) : 318 - 322
  • [40] 5FU INFUSION WITH MITOMYCIN-C (MMC) VS 5FU INFUSION WITH METHYL-CCNU (ME) IN TREATMENT OF ADVANCED UPPER GASTROINTESTINAL CANCER - PHASE-3 STUDY
    BUROKER, T
    KIM, PN
    HEILBRUN, L
    VAITKEVICIUS, V
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 310 - 310
12345